Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2025-01-01T15:42:09.753Z Has data issue: false hasContentIssue false
  • English
  • Français

The cognitive behavioural approach to the treatment of hallucinations. Is every experience of hallucination a part of the symptoms associated to psychosis - or even schizophrenia ?

Published online by Cambridge University Press:  19 July 2023

M. J. Goujon  and
E. Gallois
M. J. Goujon*
Affiliation:
Cellular Neurobiology Laboratory, Salk Institute for Biological Studies / UCSD, La Jolla, CA 92037, United States
E. Gallois
Affiliation:
Unité d’Accueil Psychothérapeutique, Centre Hospitalier de l’Agglomération Montargeoise, Montargis, France
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

We report here our experience of treating hallucinations (auditory, visual, sensorial) using Cognitive Behavioural Therapy (CBT), along with medications. Our experience goes towards the conclusion that diagnosis is usually made prior to medical treatment of symptoms with high doses of neuroleptic drugs.

Objectives

Our aim was to make a clear difference between hallucinations which need high doses of neuroleptics for cure and hallucinations that could respond to lesser drug treatment associated with CBT.

Methods

Our method was based on individual sessions of CBT.

Results

Our behavioural-cognitive method yielded high success rates as evidenced by thorough investigation into patients’ medical record including past medical history, prior drug use and life-threatening events.

This work is preliminary to a follow-up with the rigorous method for evaluation.

Conclusions

Further, we aim to promote out-patient follow-ups in our unit after a very short inpatient assessment and treatment.

Our therapeutic approach is now approved by our team and new patients are currently being included.

Disclosure of Interest

None Declared

Type
Abstract
Information
European Psychiatry , Volume 66 , Special Issue S1: Abstracts of the 31st European Congress of Psychiatry , March 2023 , pp. S481
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.